Skip to main content
TipRanks
Go Ultimate75% OFF

Passage Bio (PASG) Stock Statistics & Valuation Metrics

645 Followers

Total Valuation

Passage Bio has a market cap or net worth of $13.68M. The enterprise value is -$5.68M.

Market Cap
$13.68M
Enterprise Value
-$5.68M

Share Statistics

Passage Bio has 3,217,810 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
3,217,810
Owned by Insiders
21.90%
Owned by Institutions
14.57%

Financial Efficiency

Passage Bio’s return on equity (ROE) is -2.43 and return on invested capital (ROIC) is -100.90%.

Return on Equity (ROE)
-2.43
Return on Assets (ROA)
-0.73
Return on Invested Capital (ROIC)
-100.90%
Return on Capital Employed (ROCE)
-1.10
Revenue Per Employee
0
Profits Per Employee
-1.90M
Employee Count
24
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Passage Bio is -0.41. Passage Bio’s PEG ratio is -0.01.

PE Ratio
-0.41
PS Ratio
0.00
PB Ratio
273.51
Price to FCF
-0.42
Price to Operating Cash Flow
-0.42
PEG Ratio
-0.01

Income Statement

In the last 12 months, Passage Bio had revenue of 0 and earned -45.52M in profits. Earnings per share was -14.35.

Revenue
0
Gross Profit
-728.00K
Operating Income
-43.15M
Pretax Income
-45.52M
Net Income
-45.52M
EBITDA
-44.79M
Earnings Per Share (EPS)
-14.35

Cash Flow

In the last 12 months, operating cash flow was -32.65M and capital expenditures 0, giving a free cash flow of -32.65M billion.

Operating Cash Flow
-32.65M
Free Cash Flow
-32.65M
Free Cash Flow per Share
-10.15

Dividends & Yields

Passage Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-238.71%
Earnings Yield
-241.90%

Stock Price Statistics

Beta
2.25
52-Week Price Change
-50.18%
50-Day Moving Average
4.12
200-Day Moving Average
5.75
Relative Strength Index (RSI)
59.75
Average Volume (3m)
21.01K

Important Dates

Passage Bio upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date
Jul 30, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Passage Bio as a current ratio of 2.07, with Debt / Equity ratio of 128.02%

Current Ratio
2.07
Quick Ratio
2.07
Debt to Market Cap
0.55
Net Debt to EBITDA
0.50
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Passage Bio has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Passage Bio EV to EBITDA ratio is 0.22, with an EV/FCF ratio of 0.20.

EV to Sales
0.00
EV to EBITDA
0.22
EV to Free Cash Flow
0.20
EV to Operating Cash Flow
0.20

Balance Sheet

Passage Bio has $20.16M in cash and marketable securities with $0.00 in debt, giving a net cash position of $20.16M billion.

Cash & Marketable Securities
$20.16M
Total Debt
$0.00
Net Cash
$20.16M
Net Cash Per Share
$6.27
Tangible Book Value Per Share
$0.02

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Passage Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
28.49%

Scores

Smart Score
―
AI Score
46